Q4 Volume Gains Face New Cost and Delay Pressures

Aarti Industries' fourth quarter showed good momentum with volume growth in key products. However, the focus is now shifting to the serious pressure from rising costs and delays in important expansion projects. Whether the company can turn its sales growth into lasting value for shareholders depends on how well it handles these new difficulties.

The Impending Margin Squeeze

A major concern is the sharp 40-60% increase in raw material costs for key inputs like Benzene and Aniline. Management expects these higher costs will be passed on gradually. For example, agrochemical segments may see price adjustments within three to six months due to existing contracts. This delay means profits will likely be lower for a while, even in areas seeing volume recovery. Some areas, like dyes and pigments, might adjust prices faster. Overall profits are expected to be limited in the short term. Some competitors have been quicker to raise prices, which could give them an edge.

Geopolitical Shifts and China's Role

Aarti Industries is diversifying its sourcing away from the Middle East, which accounts for about 10% of its revenue. This shift means dealing with higher costs for spot purchases. While raw materials are available, global instability requires more expensive buying methods. A bigger change is China's 'anti-involution' policies. These include cutting subsidies and restricting exports for chemicals like Nitro chloro benzene. These moves are leading to better pricing discipline. This helps Indian chemical makers by reducing unfair competition, but China's strategy could also change global demand and competitiveness long-term.

Q4 Operational Snapshot

Volume growth in core products like DCB, Nitro Toluene, and MMA provided a solid base for the quarter. Steady performance in pharmaceuticals, dyes, pigments, and printing inks also supported operations. Demand in polymers and additives, boosted by China's electric vehicle market, and recovering U.S. volumes, showed areas of growth. However, U.S. tariffs and competition from China affected the MPDA segment. Agrochemicals also faced ongoing margin pressure despite increased volumes, showing mixed results across different areas.

Project Delays and Future Growth Risks

Aarti Industries' ambitious Zone IV projects, aimed at expanding its chlorotoluene and specialty chemical production, are delayed by three to four months. The main reason is a significant shortage of contract labor, around 30% less than expected. These project delays, possibly due to wider supply chain problems, could push back the start of these new production capabilities beyond the planned FY27. This risks reducing the expected improvements in how efficiently assets are used and financial return metrics for FY27. While management plans to lower capital spending from Rs 1125 crore in FY26 to Rs 700-800 crore in FY27, the delay in new capacity becoming productive creates a strategic risk.

Structural Weaknesses and Valuation Concerns

Aarti Industries has a net debt-to-equity ratio of 0.73x, meaning its financial borrowing needs careful watching, especially with possible delays in new projects generating sales and continuing high input costs. The company depends on China's changing industrial policies for stable pricing, which brings uncertainty. In the past, sharp jumps in raw material costs have led to significant drops in Aarti Industries' stock price, often taking 6-12 months to recover. Currently, its P/E ratio of about 48.5x is higher than competitors like SRF (40x), Deepak Nitrite (35x), and Vinati Organics (30x). This suggests investors might be too optimistic about short-term profits and not fully pricing in the risks from lower margins, project delays, and the chemical industry's natural ups and downs. Analysts generally support a long-term outlook, but often mention short-term challenges and project risks.

Forward Outlook

Management has confirmed its EBITDA guidance of Rs 1800-2200 crore for FY28, suggesting an annual growth rate of about 24%. This forecast relies on expectations of better pricing and less dumping from China. Analysts believe this will lead to higher revenues and improved financial returns by FY27 as capital spending stabilizes and factories run at higher capacity. The Indian chemical industry overall is expected to grow 8-10% annually over the next ten years. However, the success of these positive trends depends heavily on global demand and potential new price increases. While investing for the medium term could pay off, current uncertainties over profit margins and project schedules mean investors should watch closely.